Straits Times Index
3,303.19 +10.26 (+0.31%) S&P 500
5,127.79 +63.59 (+1.26%) Dow
38,675.68 +449.98 (+1.18%) Nasdaq
16,156.33 +315.33 (+1.99%) Bitcoin USD
65,186.90 +1,520.51 (+2.39%) CMC Crypto 200
1,406.06 +93.43 (+7.12%)
AZN Jan 2025 50.000 call
| Previous close | 19.52 |
| Open | 19.52 |
| Bid | 25.80 |
| Ask | 29.65 |
| Strike | 50.00 |
| Expiry date | 2025-01-17 |
| Day's range | 19.52 - 19.52 |
| Contract range | N/A |
| Volume | |
| Open interest | 105 |
GlobeNewswireCellectis Announces Completion of the Additional Equity Investment by AstraZeneca
Completion of the additional equity investment of $140M by AstraZeneca, as previously announced on November 1 and 15, 2023 NEW YORK, May 06, 2024 (GLOBE NEWSWIRE) -- Cellectis (Euronext Growth: ALCLS – NASDAQ: CLLS) a clinical-stage biotechnology company using its pioneering gene-editing platform to develop life-saving cell and gene therapies, today announced that, following clearance from the French Ministry of Economy and satisfaction of all other closing conditions, AstraZeneca (LSE/STO/Nasda
ZacksTop Analyst Reports for AstraZeneca, QUALCOMM & FedEx
Today's Research Daily features new research reports on 16 major stocks, including AstraZeneca PLC (AZN), QUALCOMM Incorporated (QCOM) and FedEx Corporation (FDX).
ZacksAmgen (AMGN) Q1 Earnings Top, Stock Up on Obesity Drug Update
Amgen (AMGN) beats first-quarter 2024 estimates for earnings and sales. Amgen is "very encouraged" by interim data from the phase II study on obesity candidate MariTide.
